NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for naproxen sodium; pseudoephedrine hydrochloride and what is the scope of patent protection?
Naproxen sodium; pseudoephedrine hydrochloride
is the generic ingredient in two branded drugs marketed by Bayer, Aurobindo Pharma, Dr Reddys Labs Inc, and Perrigo, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Eight suppliers are listed for this compound.
Summary for NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 8 |
Clinical Trials: | 2 |
DailyMed Link: | NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Reddy's Laboratories Limited | Phase 1 |
See all NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE clinical trials
Pharmacology for NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Drug Class | Nonsteroidal Anti-inflammatory Drug alpha-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Inc | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077381-001 | Sep 27, 2006 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Perrigo | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076518-001 | Mar 17, 2004 | OTC | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer | ALEVE-D SINUS & COLD | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021076-001 | Nov 29, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.